Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors
Jennifer Sykes, Alain Kaldany, Thomas L. Jang · 2024
Read Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors by Jennifer Sykes, Alain Kaldany, Thomas L. Jang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642472.txt.
Description
Jennifer Sykes, Alain Kaldany, and Thomas Jang review blood markers for testicular germ cell tumors, in a paper from twenty twenty-four. This is the most common cancer in young adult men, and outcomes are usually good. Markers guide diagnosis, risk grading, follow-up, and judging whether treatment worked.
The three classic markers miss about half of cases at diagnosis and can rise for harmless reasons. Newer candidates include tiny RNA strands, tumor DNA in blood, and stray tumor cells. One RNA marker detects the cancer with high accuracy and may flag hidden spread or leftover disease. It cannot spot one tumor type, though. Trials now under way will test how well it performs in real care.
Catalog record
| CREATOR | Jennifer Sykes, Alain Kaldany, Thomas L. Jang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |